Evidence map›Paper›PMID 17163964›Full record

ArticleImmunology2007

Altered expression and endocytic function of CD205 in human dendritic cells, and detection of a CD205-DCL-1 fusion protein upon dendritic cell maturation.

Matt Butler, Anne-Sophie Morel, William J Jordan, Efrem Eren, Susan Hue, Rachel E Shrimpton, Mary A Ritter

Open access · greenAbstract read
In one paragraph

Article in Immunology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Glycan-binding profile of DC-like cells.Glycoconjugate journal · 2020
    Article
  12. Article
  13. Stories From the Dendritic Cell Guardhouse.Frontiers in immunology · 2019
    Review
  14. Review
  15. Article
  16. N-dihydrogalactochitosan as a potent immune activator for dendritic cells.Journal of biomedical materials research. Part A · 2017
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Matt ButlerDepartment of Immunology, Imperial College London, Faculty of Medicine, Hammersmith Campus, London, UK. matt.butler@imperial.ac.uk
Anne-Sophie Morel
William J Jordan
Efrem Eren
Susan Hue
Rachel E Shrimpton
Mary A Ritter
Hammersmith Hospital · GBImperial College London · GBRutgers, The State University of New Jersey · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD205 (DEC-205) is a member of the macrophage mannose receptor family of C-type lectins. These molecules are known to mediate a wide variety of biological functions including the capture and internalization of ligands for subsequent processing and presentation by dendritic cells. Although its ligands await identification, the endocytic properties of CD205 make it an ideal target for those wishing to design vaccines and targeted immunotherapies. We present a detailed analysis of CD205 expression, distribution and endocytosis in human monocyte-derived dendritic cells undergoing lipopolysaccharide-induced maturation. Unlike other members of the macrophage mannose receptor family, CD205 was up-regulated upon dendritic cell maturation. This increase was a result of de novo synthesis as well as a redistribution of molecules from endocytic compartments to the cell surface. Furthermore, the endocytic capacity of CD205 was abrogated and small amounts of the recently identified CD205-DCL-1 fusion protein were detected in mature DC. Our results suggest that CD205 has two distinct functions -- one as an endocytic receptor on immature dendritic cells and a second as a non-endocytic molecule on mature dendritic cells -- and further highlight its potential as an immuno-modulatory target for vaccine and immunotherapy development.

Indexed as

Antigens, CDCell DifferentiationCells, CulturedDendritic CellsDown-RegulationEndocytosisHumansLectins, C-TypeLeukocytes, MononuclearLipopolysaccharidesMannose-Binding LectinsMannose ReceptorMinor Histocompatibility AntigensMonocytesOncogene Proteins, FusionPolymerase Chain ReactionAntigens, CDCD302 protein, humanDEC-205 receptorEndo180Lectins, C-TypeLipopolysaccharidesLY75-CD302 readthrough, humanMannose-Binding LectinsMannose ReceptorMinor Histocompatibility AntigensOncogene Proteins, FusionReceptors, Cell SurfaceReceptors, Mitogen

Identifiers

PMID17163964
PMCPMC2265885
OpenAlexW1977830365

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.